Global Oral Hypoglycemic Agents (OHAs) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 105

Published Date: 05 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Oral Hypoglycemic Agents (OHAs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Hypoglycemic Agents (OHAs) market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Type 2 Diabetes Mellitus accounting for % of the Oral Hypoglycemic Agents (OHAs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Sulfonylureas segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Oral Hypoglycemic Agents (OHAs) include Pfizer, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, and Novonordisk, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Oral Hypoglycemic Agents (OHAs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Sulfonylureas
    Metformin
    Thiazolidinediones
    Alpha-Glucosidase Inhibitors

Market segment by Application can be divided into
    Type 2 Diabetes Mellitus
    Type 1 Diabetes Mellitus

The key market players for global Oral Hypoglycemic Agents (OHAs) market are listed below:
    Pfizer
    GlaxoSmithKline
    Bayer
    Bristol-Myers Squibb
    Novonordisk
    Sanofi-Aventis
    Servier
    Huadong Medicine
    Wanbang Biopharmaceuticals
    Double-Crane Pharmaceutical
    Guangzhou Pharmaceutical

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Hypoglycemic Agents (OHAs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Hypoglycemic Agents (OHAs), with price, sales, revenue and global market share of Oral Hypoglycemic Agents (OHAs) from 2019 to 2022.
Chapter 3, the Oral Hypoglycemic Agents (OHAs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Hypoglycemic Agents (OHAs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Hypoglycemic Agents (OHAs) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Hypoglycemic Agents (OHAs).
Chapter 13, 14, and 15, to describe Oral Hypoglycemic Agents (OHAs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Oral Hypoglycemic Agents (OHAs) Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Oral Hypoglycemic Agents (OHAs) Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Sulfonylureas
        1.2.3 Metformin
        1.2.4 Thiazolidinediones
        1.2.5 Alpha-Glucosidase Inhibitors
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Oral Hypoglycemic Agents (OHAs) Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Type 2 Diabetes Mellitus
        1.3.3 Type 1 Diabetes Mellitus
    1.4 Global Oral Hypoglycemic Agents (OHAs) Market Size & Forecast
        1.4.1 Global Oral Hypoglycemic Agents (OHAs) Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Oral Hypoglycemic Agents (OHAs) Sales in Volume (2017-2028)
        1.4.3 Global Oral Hypoglycemic Agents (OHAs) Price (2017-2028)
    1.5 Global Oral Hypoglycemic Agents (OHAs) Production Capacity Analysis
        1.5.1 Global Oral Hypoglycemic Agents (OHAs) Total Production Capacity (2017-2028)
        1.5.2 Global Oral Hypoglycemic Agents (OHAs) Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Oral Hypoglycemic Agents (OHAs) Market Drivers
        1.6.2 Oral Hypoglycemic Agents (OHAs) Market Restraints
        1.6.3 Oral Hypoglycemic Agents (OHAs) Trends Analysis

2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Oral Hypoglycemic Agents (OHAs) Product and Services
        2.1.4 Pfizer Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 GlaxoSmithKline
        2.2.1 GlaxoSmithKline Details
        2.2.2 GlaxoSmithKline Major Business
        2.2.3 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Product and Services
        2.2.4 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Bayer
        2.3.1 Bayer Details
        2.3.2 Bayer Major Business
        2.3.3 Bayer Oral Hypoglycemic Agents (OHAs) Product and Services
        2.3.4 Bayer Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Bristol-Myers Squibb
        2.4.1 Bristol-Myers Squibb Details
        2.4.2 Bristol-Myers Squibb Major Business
        2.4.3 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Product and Services
        2.4.4 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Novonordisk
        2.5.1 Novonordisk Details
        2.5.2 Novonordisk Major Business
        2.5.3 Novonordisk Oral Hypoglycemic Agents (OHAs) Product and Services
        2.5.4 Novonordisk Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Sanofi-Aventis
        2.6.1 Sanofi-Aventis Details
        2.6.2 Sanofi-Aventis Major Business
        2.6.3 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Product and Services
        2.6.4 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Servier
        2.7.1 Servier Details
        2.7.2 Servier Major Business
        2.7.3 Servier Oral Hypoglycemic Agents (OHAs) Product and Services
        2.7.4 Servier Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Huadong Medicine
        2.8.1 Huadong Medicine Details
        2.8.2 Huadong Medicine Major Business
        2.8.3 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Product and Services
        2.8.4 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Wanbang Biopharmaceuticals
        2.9.1 Wanbang Biopharmaceuticals Details
        2.9.2 Wanbang Biopharmaceuticals Major Business
        2.9.3 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Product and Services
        2.9.4 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Double-Crane Pharmaceutical
        2.10.1 Double-Crane Pharmaceutical Details
        2.10.2 Double-Crane Pharmaceutical Major Business
        2.10.3 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
        2.10.4 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Guangzhou Pharmaceutical
        2.11.1 Guangzhou Pharmaceutical Details
        2.11.2 Guangzhou Pharmaceutical Major Business
        2.11.3 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
        2.11.4 Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Oral Hypoglycemic Agents (OHAs) Breakdown Data by Manufacturer
    3.1 Global Oral Hypoglycemic Agents (OHAs) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Oral Hypoglycemic Agents (OHAs)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Oral Hypoglycemic Agents (OHAs) Manufacturer Market Share in 2021
        3.4.2 Top 6 Oral Hypoglycemic Agents (OHAs) Manufacturer Market Share in 2021
    3.5 Global Oral Hypoglycemic Agents (OHAs) Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Oral Hypoglycemic Agents (OHAs) Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Oral Hypoglycemic Agents (OHAs) Market Size by Region
        4.1.1 Global Oral Hypoglycemic Agents (OHAs) Sales in Volume by Region (2017-2028)
        4.1.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Region (2017-2028)
    4.2 North America Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028)
    4.3 Europe Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028)
    4.4 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028)
    4.5 South America Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028)
    4.6 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Oral Hypoglycemic Agents (OHAs) Sales in Volume by Type (2017-2028)
    5.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Type (2017-2028)
    5.3 Global Oral Hypoglycemic Agents (OHAs) Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Oral Hypoglycemic Agents (OHAs) Sales in Volume by Application (2017-2028)
    6.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Application (2017-2028)
    6.3 Global Oral Hypoglycemic Agents (OHAs) Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2028)
    7.2 North America Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2028)
    7.3 North America Oral Hypoglycemic Agents (OHAs) Market Size by Country
        7.3.1 North America Oral Hypoglycemic Agents (OHAs) Sales in Volume by Country (2017-2028)
        7.3.2 North America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2028)
    8.2 Europe Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2028)
    8.3 Europe Oral Hypoglycemic Agents (OHAs) Market Size by Country
        8.3.1 Europe Oral Hypoglycemic Agents (OHAs) Sales in Volume by Country (2017-2028)
        8.3.2 Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2028)
    9.2 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2028)
    9.3 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Market Size by Region
        9.3.1 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2028)
    10.2 South America Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2028)
    10.3 South America Oral Hypoglycemic Agents (OHAs) Market Size by Country
        10.3.1 South America Oral Hypoglycemic Agents (OHAs) Sales in Volume by Country (2017-2028)
        10.3.2 South America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2028)
    11.2 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2028)
    11.3 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Market Size by Country
        11.3.1 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Oral Hypoglycemic Agents (OHAs) and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Oral Hypoglycemic Agents (OHAs)
    12.3 Oral Hypoglycemic Agents (OHAs) Production Process
    12.4 Oral Hypoglycemic Agents (OHAs) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Oral Hypoglycemic Agents (OHAs) Typical Distributors
    13.3 Oral Hypoglycemic Agents (OHAs) Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Hypoglycemic Agents (OHAs) Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Oral Hypoglycemic Agents (OHAs) Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 4. Pfizer Major Business
    Table 5. Pfizer Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 6. Pfizer Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 8. GlaxoSmithKline Major Business
    Table 9. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 10. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Bayer Basic Information, Manufacturing Base and Competitors
    Table 12. Bayer Major Business
    Table 13. Bayer Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 14. Bayer Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 16. Bristol-Myers Squibb Major Business
    Table 17. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 18. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Novonordisk Basic Information, Manufacturing Base and Competitors
    Table 20. Novonordisk Major Business
    Table 21. Novonordisk Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 22. Novonordisk Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
    Table 24. Sanofi-Aventis Major Business
    Table 25. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 26. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Servier Basic Information, Manufacturing Base and Competitors
    Table 28. Servier Major Business
    Table 29. Servier Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 30. Servier Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Huadong Medicine Basic Information, Manufacturing Base and Competitors
    Table 32. Huadong Medicine Major Business
    Table 33. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 34. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 36. Wanbang Biopharmaceuticals Major Business
    Table 37. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 38. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Double-Crane Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 40. Double-Crane Pharmaceutical Major Business
    Table 41. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 42. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Guangzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 44. Guangzhou Pharmaceutical Major Business
    Table 45. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Product and Services
    Table 46. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Global Oral Hypoglycemic Agents (OHAs) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
    Table 48. Global Oral Hypoglycemic Agents (OHAs) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 49. Market Position of Manufacturers in Oral Hypoglycemic Agents (OHAs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 50. Global Oral Hypoglycemic Agents (OHAs) Production Capacity by Company, (K MT): 2020 VS 2021
    Table 51. Head Office and Oral Hypoglycemic Agents (OHAs) Production Site of Key Manufacturer
    Table 52. Oral Hypoglycemic Agents (OHAs) New Entrant and Capacity Expansion Plans
    Table 53. Oral Hypoglycemic Agents (OHAs) Mergers & Acquisitions in the Past Five Years
    Table 54. Global Oral Hypoglycemic Agents (OHAs) Sales by Region (2017-2022) & (K MT)
    Table 55. Global Oral Hypoglycemic Agents (OHAs) Sales by Region (2023-2028) & (K MT)
    Table 56. Global Oral Hypoglycemic Agents (OHAs) Revenue by Region (2017-2022) & (USD Million)
    Table 57. Global Oral Hypoglycemic Agents (OHAs) Revenue by Region (2023-2028) & (USD Million)
    Table 58. Global Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2022) & (K MT)
    Table 59. Global Oral Hypoglycemic Agents (OHAs) Sales by Type (2023-2028) & (K MT)
    Table 60. Global Oral Hypoglycemic Agents (OHAs) Revenue by Type (2017-2022) & (USD Million)
    Table 61. Global Oral Hypoglycemic Agents (OHAs) Revenue by Type (2023-2028) & (USD Million)
    Table 62. Global Oral Hypoglycemic Agents (OHAs) Price by Type (2017-2022) & (USD/MT)
    Table 63. Global Oral Hypoglycemic Agents (OHAs) Price by Type (2023-2028) & (USD/MT)
    Table 64. Global Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2022) & (K MT)
    Table 65. Global Oral Hypoglycemic Agents (OHAs) Sales by Application (2023-2028) & (K MT)
    Table 66. Global Oral Hypoglycemic Agents (OHAs) Revenue by Application (2017-2022) & (USD Million)
    Table 67. Global Oral Hypoglycemic Agents (OHAs) Revenue by Application (2023-2028) & (USD Million)
    Table 68. Global Oral Hypoglycemic Agents (OHAs) Price by Application (2017-2022) & (USD/MT)
    Table 69. Global Oral Hypoglycemic Agents (OHAs) Price by Application (2023-2028) & (USD/MT)
    Table 70. North America Oral Hypoglycemic Agents (OHAs) Sales by Country (2017-2022) & (K MT)
    Table 71. North America Oral Hypoglycemic Agents (OHAs) Sales by Country (2023-2028) & (K MT)
    Table 72. North America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2017-2022) & (USD Million)
    Table 73. North America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2023-2028) & (USD Million)
    Table 74. North America Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2022) & (K MT)
    Table 75. North America Oral Hypoglycemic Agents (OHAs) Sales by Type (2023-2028) & (K MT)
    Table 76. North America Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2022) & (K MT)
    Table 77. North America Oral Hypoglycemic Agents (OHAs) Sales by Application (2023-2028) & (K MT)
    Table 78. Europe Oral Hypoglycemic Agents (OHAs) Sales by Country (2017-2022) & (K MT)
    Table 79. Europe Oral Hypoglycemic Agents (OHAs) Sales by Country (2023-2028) & (K MT)
    Table 80. Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country (2017-2022) & (USD Million)
    Table 81. Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country (2023-2028) & (USD Million)
    Table 82. Europe Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2022) & (K MT)
    Table 83. Europe Oral Hypoglycemic Agents (OHAs) Sales by Type (2023-2028) & (K MT)
    Table 84. Europe Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2022) & (K MT)
    Table 85. Europe Oral Hypoglycemic Agents (OHAs) Sales by Application (2023-2028) & (K MT)
    Table 86. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales by Region (2017-2022) & (K MT)
    Table 87. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales by Region (2023-2028) & (K MT)
    Table 88. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Region (2017-2022) & (USD Million)
    Table 89. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Region (2023-2028) & (USD Million)
    Table 90. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2022) & (K MT)
    Table 91. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales by Type (2023-2028) & (K MT)
    Table 92. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2022) & (K MT)
    Table 93. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales by Application (2023-2028) & (K MT)
    Table 94. South America Oral Hypoglycemic Agents (OHAs) Sales by Country (2017-2022) & (K MT)
    Table 95. South America Oral Hypoglycemic Agents (OHAs) Sales by Country (2023-2028) & (K MT)
    Table 96. South America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2017-2022) & (USD Million)
    Table 97. South America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2023-2028) & (USD Million)
    Table 98. South America Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2022) & (K MT)
    Table 99. South America Oral Hypoglycemic Agents (OHAs) Sales by Type (2023-2028) & (K MT)
    Table 100. South America Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2022) & (K MT)
    Table 101. South America Oral Hypoglycemic Agents (OHAs) Sales by Application (2023-2028) & (K MT)
    Table 102. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Region (2017-2022) & (K MT)
    Table 103. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Region (2023-2028) & (K MT)
    Table 104. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue by Region (2017-2022) & (USD Million)
    Table 105. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue by Region (2023-2028) & (USD Million)
    Table 106. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Type (2017-2022) & (K MT)
    Table 107. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Type (2023-2028) & (K MT)
    Table 108. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Application (2017-2022) & (K MT)
    Table 109. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales by Application (2023-2028) & (K MT)
    Table 110. Oral Hypoglycemic Agents (OHAs) Raw Material
    Table 111. Key Manufacturers of Oral Hypoglycemic Agents (OHAs) Raw Materials
    Table 112. Direct Channel Pros & Cons
    Table 113. Indirect Channel Pros & Cons
    Table 114. Oral Hypoglycemic Agents (OHAs) Typical Distributors
    Table 115. Oral Hypoglycemic Agents (OHAs) Typical Customers
List of Figures
    Figure 1. Oral Hypoglycemic Agents (OHAs) Picture
    Figure 2. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Type in 2021
    Figure 3. Sulfonylureas
    Figure 4. Metformin
    Figure 5. Thiazolidinediones
    Figure 6. Alpha-Glucosidase Inhibitors
    Figure 7. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Application in 2021
    Figure 8. Type 2 Diabetes Mellitus
    Figure 9. Type 1 Diabetes Mellitus
    Figure 10. Global Oral Hypoglycemic Agents (OHAs) Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
    Figure 11. Global Oral Hypoglycemic Agents (OHAs) Revenue and Forecast (2017-2028) & (USD Million)
    Figure 12. Global Oral Hypoglycemic Agents (OHAs) Sales (2017-2028) & (K MT)
    Figure 13. Global Oral Hypoglycemic Agents (OHAs) Price (2017-2028) & (USD/MT)
    Figure 14. Global Oral Hypoglycemic Agents (OHAs) Production Capacity (2017-2028) & (K MT)
    Figure 15. Global Oral Hypoglycemic Agents (OHAs) Production Capacity by Geographic Region: 2022 VS 2028
    Figure 16. Oral Hypoglycemic Agents (OHAs) Market Drivers
    Figure 17. Oral Hypoglycemic Agents (OHAs) Market Restraints
    Figure 18. Oral Hypoglycemic Agents (OHAs) Market Trends
    Figure 19. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Manufacturer in 2021
    Figure 20. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Manufacturer in 2021
    Figure 21. Oral Hypoglycemic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 22. Top 3 Oral Hypoglycemic Agents (OHAs) Manufacturer (Revenue) Market Share in 2021
    Figure 23. Top 6 Oral Hypoglycemic Agents (OHAs) Manufacturer (Revenue) Market Share in 2021
    Figure 24. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2017-2028)
    Figure 25. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region (2017-2028)
    Figure 26. North America Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028) & (USD Million)
    Figure 27. Europe Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028) & (USD Million)
    Figure 28. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028) & (USD Million)
    Figure 29. South America Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028) & (USD Million)
    Figure 30. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue (2017-2028) & (USD Million)
    Figure 31. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2017-2028)
    Figure 32. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Type (2017-2028)
    Figure 33. Global Oral Hypoglycemic Agents (OHAs) Price by Type (2017-2028) & (USD/MT)
    Figure 34. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2017-2028)
    Figure 35. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Application (2017-2028)
    Figure 36. Global Oral Hypoglycemic Agents (OHAs) Price by Application (2017-2028) & (USD/MT)
    Figure 37. North America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2017-2028)
    Figure 38. North America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2017-2028)
    Figure 39. North America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2017-2028)
    Figure 40. North America Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2017-2028)
    Figure 41. United States Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Canada Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Mexico Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Europe Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2017-2028)
    Figure 45. Europe Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2017-2028)
    Figure 46. Europe Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2017-2028)
    Figure 47. Europe Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2017-2028)
    Figure 48. Germany Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. France Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. United Kingdom Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Russia Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Italy Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2017-2028)
    Figure 54. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2017-2028)
    Figure 55. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2017-2028)
    Figure 56. Asia-Pacific Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region (2017-2028)
    Figure 57. China Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Japan Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Korea Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. India Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Southeast Asia Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Australia Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. South America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2017-2028)
    Figure 64. South America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2017-2028)
    Figure 65. South America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2017-2028)
    Figure 66. South America Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2017-2028)
    Figure 67. Brazil Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Argentina Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2017-2028)
    Figure 70. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2017-2028)
    Figure 71. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2017-2028)
    Figure 72. Middle East & Africa Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region (2017-2028)
    Figure 73. Turkey Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Egypt Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Saudi Arabia Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. South Africa Oral Hypoglycemic Agents (OHAs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Manufacturing Cost Structure Analysis of Oral Hypoglycemic Agents (OHAs) in 2021
    Figure 78. Manufacturing Process Analysis of Oral Hypoglycemic Agents (OHAs)
    Figure 79. Oral Hypoglycemic Agents (OHAs) Industrial Chain
    Figure 80. Sales Channel: Direct Channel vs Indirect Channel
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novonordisk
Sanofi-Aventis
Servier
Huadong Medicine
Wanbang Biopharmaceuticals
Double-Crane Pharmaceutical
Guangzhou Pharmaceutical

Related Reports

Global Oral Hypoglycemic Agents (OHAs) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Oral Hypoglycemic Agents (OHAs) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 03 Mar 2021

date Pharma & Healthcare

The Oral Hypoglycemic Agents (OHAs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

oral hypoglycemic agents ohas

Oral Hypoglycemic Agents (OHAs)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>